Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-22

Clinical Trial Update: 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine [Phase 3]

View source ↗

Summary

Phase 3 trial update on levocetirizine for allergic rhinitis, featuring 3-D visualization of anti-obstructive effects; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine (Levocetirizine)

Snippet

Sponsor: Clinical Research International Limited | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED